Today: 22 December 2025
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

Earnings Shock: Huge Loss on India Exit and Plunging Sales FMC Corporation stunned the market with a far worse-than-expected third quarter, driven by a massive one-time hit in its international operations. The Philadelphia-based crop protection company reported a GAAP net
30 October 2025
 ·  ·  ·  ·  · 
Conduent’s Ticket Machine Revolution Debuts in Italy Amid Data Breach Fallout and Market Buzz

Conduent’s Ticket Machine Revolution Debuts in Italy Amid Data Breach Fallout and Market Buzz

Conduent Launches Next-Gen Ticket Kiosk in Italy Conduent’s DOT1 ticket vending machine, now deployed by Italy’s SETA S.p.A., features a multimedia touch-screen interface and supports contactless payments, real-time travel info, and cross-service ticketing businesswire.com. Conduent Business Solutions is making headlines
30 October 2025
 ·  ·  ·  ·  · 
Crocs Stock Soars on Surprise Earnings Beat – Can the ‘Ugly Shoe’ Icon Stage a Comeback?

Crocs Stock Soars on Surprise Earnings Beat – Can the ‘Ugly Shoe’ Icon Stage a Comeback?

Strong Q3 Results Spark a Stock Surge Crocs (CROX) stock jumped over 7% on Thursday after the foam-footwear maker reported better-than-expected third-quarter earnings stockstory.org. The company’s Q3 revenue of $996.3 million, though down 6.2% from a year ago, beat analyst
30 October 2025
 ·  ·  ·  ·  · 
Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

BMY Stock Bounces After Earnings – Recent Performance Bristol Myers Squibb’s stock has been under pressure for most of 2025, but the Q3 report provided a much-needed boost. Heading into earnings, BMY shares were near 52-week lows, reflecting investor skittishness
30 October 2025
 ·  ·  ·  · 
1 … 91 92 93 94 95 … 232
Go toTop